Top Markets
Coin of the day
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Ранг среди акций #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Цена акции
$3.45
Последняя синхронизация: 2021-09-21
Рыночная капитализация
$4.29M
Изменение (1 день)
2.07%
Изменение (1 год)
0.00%
Страна
US
Торговля AzurRx BioPharma, Inc. (AZRX)

Категория

История цены акций AzurRx BioPharma, Inc. (AZRX)
Наивысшая цена закрытия: $5.04 2021-09-01

Наименьшая цена закрытия: $50.52 2016-10-01
История цены акций AzurRx BioPharma, Inc. с 2016 по 2026
Годовая динамика цены акций
Год Результативность
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE